Mode
Text Size
Log in / Sign up

FFR-guided complete revascularization reduces unplanned revascularization in MI patients with multivessel CADComplete Heart Repair May Stop Future Emergencies

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider FFR-guided complete revascularization for reduced unplanned revascularization in MI with multivessel CAD, but interpret cautiously due to heterogeneity.

This systematic review and meta-analysis included 3,054 patients with myocardial infarction and multivessel coronary artery disease during index hospitalization. It compared FFR-guided complete revascularization to culprit-only revascularization, with a follow-up of 12.0 months. The primary outcome was major adverse cardiac events (MACE), with secondary outcomes including unplanned revascularization, recurrent MI, and major bleeding.

Main results showed that FFR-guided complete revascularization reduced the risk of unplanned revascularization (RR 0.43, 95% CI: 0.21-0.87) and may reduce the risk of MACE (RR 0.63, 95% CI: 0.37-1.05) compared to culprit-only revascularization. For recurrent MI, there was no significant difference (RR 0.9, 95% CI: 0.61-1.33). Major bleeding occurred in 23 of 1,373 patients in the FFR-guided group and 29 of 1,681 in the culprit-only group, indicating low risk in both, though exact effect sizes were not reported.

Key limitations include high heterogeneity (I² = 90% for MACE and 88% for unplanned revascularization), with moderate heterogeneity for recurrent MI (I² = 30%). Safety data on serious adverse events, discontinuations, and tolerability were not reported, and funding or conflicts were not disclosed. In practice, FFR-guided complete revascularization may reduce unplanned revascularizations and potentially MACE, but results should be interpreted with caution due to variability and incomplete safety profile.

Imagine waking up from heart surgery, only to return to the hospital weeks later for another emergency procedure. This is a nightmare scenario for many patients with heart disease.

Doctors often face a tough choice during these surgeries. They must decide whether to fix just the one blocked artery causing the heart attack or to repair all the blocked vessels in the heart.

The Surprising Shift

Heart attacks happen when blood flow stops in the heart muscle. When this happens, doctors rush to open the main blocked artery. This is called culprit-only revascularization.

But many patients have more than one blocked artery. These extra blockages can cause future heart attacks or other serious problems. For years, doctors debated whether fixing these extra blockages during the first surgery was worth the risk.

What Scientists Didn't Expect

Now, new research offers a clearer answer. A team of scientists looked at three major studies involving over 3,000 patients. These patients had heart attacks and multiple blocked arteries.

The doctors used a tool called fractional flow reserve, or FFR. Think of FFR as a pressure gauge. It measures how well blood flows through each artery. It tells doctors exactly which blockages need fixing.

Many people live with multiple blockages without knowing it. If a doctor only fixes the main problem, the other blockages remain. These hidden problems can lead to sudden heart attacks later on.

Current treatments often leave these other issues untreated. Patients might feel fine for a while, then face another crisis. This creates a cycle of hospital visits and stress.

The FFR tool acts like a traffic cop for your blood vessels. It checks each road to see if it is wide enough for cars to pass safely.

If a road is too narrow, the tool signals the surgeon to fix it. By fixing all the narrow roads at once, doctors clear the entire traffic jam. This prevents cars from getting stuck later.

The researchers combined data from three randomized controlled trials. These studies included 3,054 patients. Most of the participants were men.

The doctors compared two groups. One group received complete repair of all blockages. The other group received repair of only the main blocked artery.

They followed everyone for at least one year. This gave them enough time to see if problems appeared later.

The results were promising for patients. Those who got complete repair had fewer unplanned return visits to the hospital.

The risk of needing another surgery dropped significantly. In plain English, fixing everything at once kept patients out of the emergency room.

The risk of having another heart attack did not change much between the two groups. However, the overall risk of major heart events was lower in the complete repair group.

This doesn't mean this treatment is available yet.

There is an important catch to understand. The study showed a potential benefit, but the results were not perfect. The confidence in the overall result was not very high.

This means we need more proof before changing standard practice everywhere. Science takes time to build a solid case.

Cardiologists agree that this is a significant step forward. They have long wondered if fixing all blockages was safe. This study suggests it is likely safe and helpful.

However, experts warn against rushing to change how hospitals operate. Every patient is different. Some may need only one repair, while others need more.

If you have had a heart attack, talk to your doctor about your specific arteries. Ask if you have more than one blockage.

Do not assume that fixing just the main problem is enough. Ask your care team about using tools like FFR to guide their decisions.

Your heart deserves the best chance to stay healthy. Understanding your options can help you make informed choices about your care.

The study has some weaknesses. The group of patients was mostly men. We do not know if the results apply equally to women.

Also, the overall confidence in the main result was low. This means the data is not as strong as we would like. More research is needed to confirm these findings.

More studies are coming soon. Researchers will look at larger groups of people. They will also study women and other diverse populations.

Until then, doctors will continue to use their best judgment. They will weigh the risks and benefits for each patient.

The goal is to keep patients safe and healthy. We are moving closer to a time where fixing all blockages becomes standard care. This could save many lives in the future.

Study Details

Study typeMeta analysis
Sample sizen = 3,054
EvidenceLevel 1
Follow-up12.0 mo
PublishedApr 2026
View Original Abstract ↓
In patients with myocardial infarctions (MI) and multivessel coronary artery disease (CAD), the effect of fractional flow-reserve (FFR)-guided complete revascularization during index hospitalization versus culprit-only revascularization remains unclear. Our objective is to determine whether FFR-guided complete revascularization during index hospitalization reduces major adverse cardiac events (MACE) among patients with MI and multivessel CAD. We systematically searched MEDLINE, EMBASE, and the Cochrane Library for randomized controlled trials (RCTs) comparing FFR-guided complete versus culprit-only revascularization in patients with MI and multivessel CAD. The primary outcome was MACE, as defined by a composite endpoint of all-cause death, MI or unplanned revascularization, at a minimum 1-year follow-up. Count data were pooled across trials using random-effects models to estimate risk ratios (RRs) and 95% confidence intervals (CIs). A total of 3 RCTs (n = 3,054) were included. The majority (77.5%) of participants were male. The pooled RR of MACE for FFR-guide complete versus culprit-only revascularization was 0.63 (95% CI: 0.37-1.05; I = 90%). FFR-guided complete revascularization was associated with reduced unplanned revascularization events, with a pooled RR 0.43 (95% CI: 0.21-0.87; I = 88%). There was no significant difference in the risk of recurrent MI (RR: 0.9; 95% CI: 0.61-1.33; I =30%). The risk of major bleeding was low in both FFR-guided complete (23/1373) and culprit-only (29/1681) revascularization groups across the 3 trials. In conclusion, in patients with MI and multivessel CAD, FFR-guided complete revascularization during the index hospitalization reduces the risk of unplanned revascularizations and may reduce the risk of MACE compared to culprit-only revascularization.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.